Table 2.

Expression quantitative trait loci (eQTL) for pathway single-nucleotide polymorphisms (SNPs) in normal pancreatic tissue from GTEx and an independent replication set

Pathway geneChrr2 with rs876493*SNPeQTL geneGTEx pancreas (n = 220)
Independent LTG pancreas (n = 95)
PEffect size (β)PEffect size (β)
ERBB2, PGAP317N/Ars876493 §,‖PGAP33.90 × 10−7−0.241.16 × 10−5−.43
TCAP, STARD3, PNMT17.636rs3764351 §,‖PGAP35.70 × 10−9−.309.70 × 10−5−.47
GRB7, MIEN117.3508rs4795393§PGAP34.00 × 10−10−.303.83 × 10−5−.45
GSDMB, ZPBP217.3046rs12453507§PGAP32.70 × 10−7−.222.80 × 10−5−.45
CASP710rs3124737CASP72.50 × 10−8.42.02.28
Pathway geneChrr2 with rs876493*SNPeQTL geneGTEx pancreas (n = 220)
Independent LTG pancreas (n = 95)
PEffect size (β)PEffect size (β)
ERBB2, PGAP317N/Ars876493 §,‖PGAP33.90 × 10−7−0.241.16 × 10−5−.43
TCAP, STARD3, PNMT17.636rs3764351 §,‖PGAP35.70 × 10−9−.309.70 × 10−5−.47
GRB7, MIEN117.3508rs4795393§PGAP34.00 × 10−10−.303.83 × 10−5−.45
GSDMB, ZPBP217.3046rs12453507§PGAP32.70 × 10−7−.222.80 × 10−5−.45
CASP710rs3124737CASP72.50 × 10−8.42.02.28
*

Linkage disequilibrium r2 values are derived from LDLink EUR population data. Chr = chromosome; eQTL = expression quantitative trait loci; FDR = false discovery rate; LTG = Laboratory of Translational Genomics; TSS = transcription start site.

eQTL in pancreas FDR (≤ 0.05) using roughly 1 Mb cis-window around TSS. Statistical test was two-sided.

Beta (β) eQTL directional effect for risk allele.

§

SNP in the Nikolsky breast cancer chr17 amplicon gene set.

SNP in the Pujana ATM PCC network gene set.

Table 2.

Expression quantitative trait loci (eQTL) for pathway single-nucleotide polymorphisms (SNPs) in normal pancreatic tissue from GTEx and an independent replication set

Pathway geneChrr2 with rs876493*SNPeQTL geneGTEx pancreas (n = 220)
Independent LTG pancreas (n = 95)
PEffect size (β)PEffect size (β)
ERBB2, PGAP317N/Ars876493 §,‖PGAP33.90 × 10−7−0.241.16 × 10−5−.43
TCAP, STARD3, PNMT17.636rs3764351 §,‖PGAP35.70 × 10−9−.309.70 × 10−5−.47
GRB7, MIEN117.3508rs4795393§PGAP34.00 × 10−10−.303.83 × 10−5−.45
GSDMB, ZPBP217.3046rs12453507§PGAP32.70 × 10−7−.222.80 × 10−5−.45
CASP710rs3124737CASP72.50 × 10−8.42.02.28
Pathway geneChrr2 with rs876493*SNPeQTL geneGTEx pancreas (n = 220)
Independent LTG pancreas (n = 95)
PEffect size (β)PEffect size (β)
ERBB2, PGAP317N/Ars876493 §,‖PGAP33.90 × 10−7−0.241.16 × 10−5−.43
TCAP, STARD3, PNMT17.636rs3764351 §,‖PGAP35.70 × 10−9−.309.70 × 10−5−.47
GRB7, MIEN117.3508rs4795393§PGAP34.00 × 10−10−.303.83 × 10−5−.45
GSDMB, ZPBP217.3046rs12453507§PGAP32.70 × 10−7−.222.80 × 10−5−.45
CASP710rs3124737CASP72.50 × 10−8.42.02.28
*

Linkage disequilibrium r2 values are derived from LDLink EUR population data. Chr = chromosome; eQTL = expression quantitative trait loci; FDR = false discovery rate; LTG = Laboratory of Translational Genomics; TSS = transcription start site.

eQTL in pancreas FDR (≤ 0.05) using roughly 1 Mb cis-window around TSS. Statistical test was two-sided.

Beta (β) eQTL directional effect for risk allele.

§

SNP in the Nikolsky breast cancer chr17 amplicon gene set.

SNP in the Pujana ATM PCC network gene set.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close